Results 21 to 30 of about 9,607 (202)
Shuai Miao,1,2 Lan Zou,1,2 Guanglei Wang,1,2 Xiuli Wang,1,2 Su Liu,1,2 Mengzhu Shi1,21Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, People’s Republic of China; 2Department of Anesthesiology, The Affiliated ...
Miao S +5 more
doaj +1 more source
Butorphanol pre-treatment prevents myoclonus induced by etomidate
QUESTIONS UNDER STUDY: Myoclonic movements are common problems during induction of anaesthesia with etomidate. The myoclonus occurring after etomidate administration may represent a form of seizure.
Liang He +4 more
doaj +2 more sources
Effects of etomidate use in ICU patients on ventilator therapy: a study of 12,526 patients in an open database from a single center [PDF]
Background There is a debate regarding the safety of etomidate. We evaluated the effects of etomidate on mortality in a large cohort of critical care patients.
Ha Yeon Park +5 more
doaj +1 more source
Polymorphisms of pharmacogenetic candidate genes affect etomidate anesthesia susceptibility
Purpose: Etomidate is widely used in general anesthesia and sedation, and significant individual differences are observed during anesthesia induction.
Lulin Ma +11 more
doaj +1 more source
Etomidate is a hypnotic drug used as an intravenous anaesthetic induction agent. Etomidate causes myoclonic movements in 50-80% patients after induction which makes it less desirable for induction.
Mukesh K Sunda +3 more
doaj +1 more source
Background: Etomidate is an efficient general anesthetic associated with injection pain. Etomidate-Lipuro is its lipid emulsion, suggested to have less adverse effects. We aim to compare the injection pain of etomidate vs.
Alireza Saliminia, Niloofar Esfahanian
doaj +1 more source
Behavioral and steroidogenic pharmacology of phenyl ring substituted etomidate analogs in rats
Background Cushing’s syndrome is an endocrine disorder characterized by the overproduction of adrenocortical steroids. Steroidogenesis enzyme inhibitors are the mainstays of pharmacological treatment. Unfortunately, they produce significant side effects.
Megan McGrath +2 more
doaj +1 more source
Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in cushing's syndrome [PDF]
We determined the adrenostatic potential of low-dose nonhypnotic etomidate in six patients with Cushing's syndrome (ectopic Cushing's syndrome,n=2; Cushing's disease,n=3; bilateral adrenal adenoma,n=1). Etomidate was given as a continuous infusion for 32
Winkelmann, W. +5 more
core +1 more source
Background: The very idea of faster recovery and early ambulation has prompted patients to opt for day care surgeries. The concept of ERAS (enhanced recovery after surgery) is the backbone to achieve this goal.
Jyoti Kale +3 more
doaj +1 more source
Background Etomidate is an imidazole derivative that is widely used in the emergency department for Rapid Sequence Intubation (RSI). Although it has a safe hemodynamic profile, there are some concerns about its suppressant effects on the adreno-cortical ...
Jafar Rahimi Panahi +5 more
doaj +1 more source

